Efficacy and Safety of Umbralisib, Ublituximab (U2), and U2 Plus Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)John M. Burke,Gustavo Fonseca,Wojciech Jurczak, Jason Melear,Miguel Islas-Ohlmayer,James A Reeves,Parameswaran Venugopal,Tomasz Wróbel,Don Stevens,John M. Pagel,Jerome Goldschmidt,Hari P. Miskin,Peter Sportelli,Owen A. O'Connor,Nilanjan GhoshBlood(2021)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要